Colonoscopy versus biennial FIT screening: a post hoc sustained-strategy analysis of the COLONPREV Trial
Open Access
Abstract
Background: Pragmatic colorectal cancer (CRC) screening trials compare colonoscopy with faecal immunochemical testing (FIT), but differences in adherence complicate interpretation of comparative outcomes. Objective: To compare 10-year risks of CRC mortality, CRC incidence and all-cause mortality under one-time colonoscopy versus sustained FIT strategies in the COLONPREV Trial. Design: We conducted a post hoc per-protocol analysis of 17 270 screening initiators aged 50–69 years in eight Spanish regions, using inverse probability weighting to adjust for observed confounding and informative protocol deviations. Results: Weighted 10-year risks were similar for CRC incidence (0.80% FIT vs 0.86% colonoscopy; risk difference (RD) 0.06%, 95% CI −0.25% to 0.37%) and all-cause mortality (4.02% vs 4.09%; RD 0.07%, 95% CI −0.76% to 0.84%). CRC mortality was lower with colonoscopy (0.072% FIT vs 0.042% colonoscopy; RD −0.03%, 95% CI −0.12% to 0.06%), but estimates were imprecise. Conclusion: Sustained colonoscopy and FIT showed similar 10-year outcomes overall, highlighting the importance of adherence pathways in pragmatic screening trials. Trial registration number: ClinicalTrials.gov: NCT00906997 .Keywords
Funding Information
- Fundación Científica Asociación Española Contra el Cáncer (AECC07185)
- Fundación Científica Asociación Española Contra el Cáncer (GCB13131592CAST)
- Instituto de Salud Carlos III (PI08/90717)
- Instituto de Salud Carlos III. In Catalonia
- Agència de Gestió d'Ajuts Universitaris i de Recerca (2009SGR849)
- Agència de Gestió d'Ajuts Universitaris i de Recerca (2014SGR135)
- Agència de Gestió d'Ajuts Universitaris i de Recerca (2017SGR653)
- Agència de Gestió d'Ajuts Universitaris i de Recerca (2021SGR716)
- Basque Country
- Obra Social de Kutxa, Diputación Foral de Gipuzkoa (DFG 07/5)
- Departamento de Sanidad del Gobierno Vasco
- EITB-Maratoia (BIO 07/CA/19)
This publication has 11 references indexed in Scilit:
- Can Colonoscopy Still Be Promoted as the Best Choice for Colorectal Cancer Screening?Gastroenterology, 2026
- Effect of long-term adherence on faecal immunochemical test positivity rate, positive predictive value and detection rate in organised population-based colorectal cancer screeningGut, 2026
- Is a Goldilocks Solution for Colorectal Cancer Screening Just a Fairy Tale? Overdiagnosis Versus Later Diagnosis of Premalignant LesionsGastroenterology, 2026
- Colonoscopy versus faecal immunochemical testing in COLONPREVThe Lancet, 2025
- Colonoscopy versus faecal immunochemical testing in COLONPREV – Authors' replyThe Lancet, 2025
- The Comparative Trials of Fecal Immunochemical Testing vs Colonoscopy: What COLONPREV Tells Us and What to Anticipate From the OthersClinical Gastroenterology and Hepatology, 2025
- Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trialThe Lancet, 2025
- Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related DeathNew England Journal of Medicine, 2022
- Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysisStatistics in Medicine, 2016
- Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer ScreeningNew England Journal of Medicine, 2012